Re‐re‐biopsy? How much tumor is enough in the era of precision oncology?
Article in Asia-Pacific Journal of Clinical Oncology (October 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis
Article in Frontiers in Oncology (June 2022)
A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The ‘LUNGFUL’ Study
Article in Cancers (June 2021)